Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says
Remdesivir, which recently received emergency use approval to treat patients with COVID-19, will be tested in an inhaled version, biotech Gilead Sciences said on Monday.
via FOX NEWS https://ift.tt/2zUBRaf
No comments:
Post a Comment